参考文献/References:
[1] 中国高血压防治指南(2018年修订版)[J].中国心血管杂志,2019,24(1):24-56.
[2] Wang Z,Chen Z,Zhang L,et al. Status of hypertension in China:results from the China hypertension survey,2012-2015[J]. Circulation,2018,137(22):2344-2356.
[3] Zhou M,Wang H,Zeng X,et al. Mortality,morbidity,and risk factors in China and its provinces,1990-2017:a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet,2019,394(10204):1145-1158.
[4] Banegas JR,Ruilope LM,de la Sierra A,et al. High prevalence of masked uncontrolled hypertension in people with treated hypertension[J]. Eur Heart J,2014,35(46):3304-3312.
[5] Boggia J,Li Y,Thijs L,et al. Prognostic accuracy of day versus night ambulatory blood pressure:a cohort study[J]. Lancet,2007,370(9594):1219-1229.
[6] Yang WY,Melgarejo JD,Thijs L,et al. Association of office and ambulatory blood pressure with mortality and cardiovascular outcomes[J]. JAMA,2019,322(5):409-420.
[7] Kario K,Shin J,Chen CH,et al. Expert panel consensus recommendations for ambulatory blood pressure monitoring in Asia:The HOPE Asia Network[J]. J Clin Hypertens(Greenwich),2019,21(9):1250-1283.
[8] Williams B,Mancia G,Spiering W,et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension:The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension:The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension[J]. J Hypertens,2018,36(10):1953-2041.
[9] Lusardi P,Preti P,Savino S,et al. Effect of bedtime melatonin ingestion on blood pressure of normotensive subjects[J]. Blood Press Monit,1997,2(2):99-103.
[10] Lang H,Li Q,Yu H,et al. Activation of TRPV1 attenuates high salt-induced cardiac hypertrophy through improvement of mitochondrial function[J]. Br J Pharmacol,2015,172(23):5548-5558.
[11] Ferrannini E,Cushman WC. Diabetes and hypertension:the bad companions[J]. Lancet,2012,380(9841):601-610.
[12] Steinhorst AP,Gon?alves SC,Oliveira AT,et al. Influence of sleep apnea severity on blood pressure variability of patients with hypertension[J]. Sleep Breath,2014,18(2):397-401.
[13] Mezue K,Isiguzo G,Madu C,et al. Nocturnal non-dipping blood pressure profile in black normotensives is associated with cardiac target organ damage[J]. Ethn Dis,2016,26(3):279-284.
[14] 申明珠,陈书艳.血压昼夜节律异常与靶器官损害[J].国际心血管病杂志,2021,48(4):229-233.
[15] Yang K,Zhu X,Feng Y,et al. Abnormal blood pressure circadian rhythms are relevant to cerebral infarction and Leukoaraiosis in hypertensive patients[J]. BMC Neurol,2020,20(1):36.
[16] 单海燕,李雪莲,李婉,等.老年高血压患者血压昼夜节律与炎症因子、尿微量白蛋白的相关性[J].中国老年学杂志,2014,34(2):337-339.
[17] Luo Y,Ren L,Jiang M,et al. Anti-hypertensive efficacy of amlodipine dosing during morning versus evening:a meta-analysis [J]. Rev Cardiovasc Med,2019,20(2):91-98.
[18] Yan P,Luo Y,Zhang J,et al. Effect of administration of low-dose irbesartan and hydrochlorothiazide combined with levamlodipine at different times on the circadian rhythm of blood pressure and the levels of MMPs and TIMPs in non-dipper patients with grade 1 and 2 hypertension[J]. J Clin Hypertens (Greenwich),2023,25(2):137-145.
[19] Liu J,Su X,Nie Y,et al. Dosing time matters? Nighttime vs. daytime administration of nifedipine gastrointestinal therapeutic system (GITS) or amlodipine on non-dipper hypertension:a randomized controlled trial of NARRAS[J]. Front Cardiovasc Med,2021,8:755403.
[20] Poulter NR,Savopoulos C,Anjum A,et al. Randomized crossover trial of the impact of morning or evening dosing of antihypertensive agents on 24-hour ambulatory blood pressure[J]. Hypertension,2018,72(4):870-873.
[21] Bowles NP,Thosar SS,Herzig MX,et al. Chronotherapy for hypertension[J]. Curr Hypertens Rep,2018,20(11):97.
[22] Muxfeldt ES,Bloch KV,Nogueira AR,et al. Twenty-four hour ambulatory blood pressure monitoring pattern of resistant hypertension[J]. Blood Press Monit,2003,8(5):181-185.
[23] Hermida RC,Ayala DE,Mojón A,et al. Effects of time of antihypertensive treatment on ambulatory blood pressure and clinical characteristics of subjects with resistant hypertension[J]. Am J Hypertens,2010,23(4):432-439.
[24] 孙宁玲,喜杨,荆珊,等.左旋氨氯地平的时间药理学对纠正老年非杓型高血压的作用[J].中华高血压杂志,2007(1):26-29.
[25] Hermida RC,Ayala DE,Mojón A,et al. Influence of circadian time of hypertension treatment on cardiovascular risk:results of the MAPEC study[J]. Chronobiol Int,2010,27(8):1629-1651.
[26] Hermida RC,Crespo JJ,Domínguez-Sardi?a M,et al. Bedtime hypertension treatment improves cardiovascular risk reduction:the Hygia Chronotherapy Trial[J]. Eur Heart J,2020,41(48):4565-4576.
[27] Mackenzie IS,Rogers A,Poulter NR,et al. Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK(TIME study):a prospective,randomised,open-label,blinded-endpoint clinical trial[J]. Lancet,2022,400(10361):1417-1425.
[28] Stergiou G,Brunstr?m M,Macdonald T,et al. Bedtime dosing of antihypertensive medications:systematic review and consensus statement:International Society of Hypertension position paper endorsed by World Hypertension League and European Society of Hypertension[J]. J Hypertens,2022,40(10):1847-1858.
相似文献/References:
[1]孙刚,黄冠华,综述.高血压合并心力衰竭的治疗策略[J].心血管病学进展,2016,(2):201.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.027]
SUN Gang,HUANG Guanhua.Treatment Strategy of Hypertension with Heart Failure[J].Advances in Cardiovascular Diseases,2016,(10):201.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.027]
[2]范贵娟,综述,徐瑞,等.盐敏感性高血压的研究进展[J].心血管病学进展,2016,(4):364.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.010]
FAN Guijuan,XU Rui.Research Progress of Salt Sensitive Hypertension[J].Advances in Cardiovascular Diseases,2016,(10):364.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.010]
[3]陈源源.钙通道阻滞剂在降压治疗中的应用[J].心血管病学进展,2015,(6):662.[doi:10.3969/j.issn.1004-3934.2015.06.002]
CHEN Yuanyuan.Application of Calcium Channel Blockers in Hypertension Treatment[J].Advances in Cardiovascular Diseases,2015,(10):662.[doi:10.3969/j.issn.1004-3934.2015.06.002]
[4]张瑞 毛露 孙硕 Dirk Hermann 陈艾东.内皮素-1干预成为高血压治疗新靶点的展望[J].心血管病学进展,2019,(7):969.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.000]
ZHANG Rui MAO LuSUN ShuoDIRK Hermann CHEN Aidong.The Prospect of Endothelin-1 Intervention as A New Target for the Treatment of Hypertension[J].Advances in Cardiovascular Diseases,2019,(10):969.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.000]
[5]张毅,柳志红.动态血压监测在高血压中的应用现状与问题[J].心血管病学进展,2019,(6):848.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.003]
ZHANG Yi,LIU Zhihong.Current status and nsolved Pproblems of Ambulatory Blood Pressure Monitoring for the Management of Hypertension[J].Advances in Cardiovascular Diseases,2019,(10):848.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.003]
[6]黄秋瑾 胡蓉.高血压合并糖尿病患者血压控制率和控制目标的探讨[J].心血管病学进展,2019,(7):973.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.002]
HUANG QiujinHU Rong.Discussion on Blood Pressure Control Rate and Control Target in Patients with Hypertension Complicated with Diabetes[J].Advances in Cardiovascular Diseases,2019,(10):973.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.002]
[7]张旭明 王曦.高血压对认知功能的影响[J].心血管病学进展,2019,(7):977.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.003]
ZHANG Xuming,WANG Xi.The Relationship Between Hypertension and Cognitive Function[J].Advances in Cardiovascular Diseases,2019,(10):977.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.003]
[8]凌梦军 陈明凌梦军.阻塞性睡眠呼吸暂停低通气综合征与高血压关系的研究进展[J].心血管病学进展,2019,(5):722.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.015]
[9]李波 郭毅 田进文 邓珏琳.高血压合并2型糖尿病的治疗进展[J].心血管病学进展,2019,(9):1196.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.002]
LI Bo,GUO Yi,TIAN Jinwen,et al.Therapy in Hypertensive Patients with Type 2 Diabetes Mellitus[J].Advances in Cardiovascular Diseases,2019,(10):1196.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.002]
[10]王继航 赵施皓 李开亮 田进文 李玉龙 付士辉 沈明志 邓珏琳.远程医疗在高血压病管理中的研究进展[J].心血管病学进展,2019,(9):1199.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.003]
WANG Jihang,ZHAO Shihao,LI Kailiang,et al.Telemedicine in Hypertension Management[J].Advances in Cardiovascular Diseases,2019,(10):1199.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.003]
[11]罗富健 赵若楠.高血压时间治疗学的研究与展望[J].心血管病学进展,2019,(9):1237.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.013]
LUO Fujian ZHAO Ruonan.Chronotherapy of Hypertension[J].Advances in Cardiovascular Diseases,2019,(10):1237.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.013]